期刊文献+

内皮抑素对肝癌HepG-2细胞生长和血管内皮生长因子表达的影响 被引量:1

Effect of endostatin on growth and VEGF expression of HepG-2 Cells
下载PDF
导出
摘要 目的:探讨内皮抑素对人肝癌细胞株HepG-2细胞生长和血管内皮生长因子(VEGF)表达的影响及其可能的机制。方法:采用MTT法检测不同浓度的内皮抑素作用不同时间后对HepG-2细胞生长的抑制作用;电镜观察加药前后HepG-2细胞超微结构的变化;免疫组织化学法检测内皮抑素作用前后HepG-2细胞中存活素表达的改变;RT-PCR法检测加药前后HepG-2细胞中VEGF基因表达的变化。结果:内皮抑素能抑制HepG-2细胞的生长增殖,呈剂量-时间依赖性,并诱导细胞凋亡;内皮抑素作用后HepG-2细胞中存活素表达明显减少,VEGF表达明显减少。结论:内皮抑素通过下调存活素的表达,诱导HepG-2细胞的凋亡、抑制其增殖,并能显著降低HepG-2细胞中VEGF的表达。 Objective: To evaluate the inhibitory effect and possible mechanisms of endostatin on HepG-2 cells and the expression of VEGF, and to provide experimental evidence for clinical treatment of hepatoma with endostatin. Methods: MTT assay was used to observe the inhibitory effects of endostatin on HepG-2 cells at various concentrations and different time points. Ultrastructural changes of HepG-2 were examined under an electron microscopy. The expression of survivin protein was analyzed by immunocytochemistry before and after endostatin treatment. VEGF mRNA content was determined by RTPCR test. Results: The growth of HepG-2 cells was significantly inhibited by endostatin in a dose-time-dependent fashion and significant apoptosis was presented. Immunohistochemical results showed that the expression of survivin protein decre assed obviously after being treated by endostation. The expression of VEGF in HepG-2 cells was inhibited by endostatin. Conclusion : Endostatin can inhibit the proliferation and induce apoptosis of HepG-2 cells by decreasing expression of survivin protein, and endostatin can inhibit the expression of VEGF.
出处 《解剖学杂志》 CAS CSCD 北大核心 2009年第2期159-161,共3页 Chinese Journal of Anatomy
关键词 内皮抑素 肝癌细胞 凋亡 存活素 血管内皮生长因子 endostatins HepG 2 cell line apoptosis survivin vascular endothelial growth factor
  • 相关文献

参考文献2

二级参考文献12

  • 1王伟国,薛惠斌,苏长青,崔贞福,聂明明,Jonathan Sham,吴孟超,钱其军.基因-病毒治疗系统CNHK200-hA对肺癌治疗的研究[J].中华肿瘤杂志,2005,27(2):69-72. 被引量:9
  • 2Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med, 1991, 324:1-8.
  • 3O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 1997, 88:277- 285.
  • 4Boehm T, Folkman J, Browder T, et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature, 1997, 390:404-407.
  • 5Chen QR, Kumar D, Stass SA, et al. Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice. Cancer Res, 1999, 59:3308-3312.
  • 6Feldman AL, Alexander HR, Hewitt SM, et al. Effect of retroviral endostatin gene transfer on subcutaneous and intraperitoneal growth of routine tumors. J Nat] Cancer Inst, 2001, 93:1014-1020.
  • 7Feldman AL, Restifo NP, Alexander HR, et al. Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice. Cancer Res, 2000, 60:1503- 1506.
  • 8Indraecolo S, Cola E, Rosato A, et al. Differential effects of angiostatin, endostatin and interferon-α ( 1 ) gene transfer on in vivo growth of human breast caneer eells. C, ene Ther, 2002, 9: 867-878.
  • 9Santer BV, Martinet O, Zhang WJ, et al. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases. Proc Nail Acad Sci USA, 2000, 97:4802-4807.
  • 10DeLisser HM,Christofidou-Solmidou M,Strieter RM,et al.Involvement of endothelial PEVAM-1/CD31 in angiogenesis. Am J Pathol, 1997, 151:67-677.

共引文献39

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部